Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Functional 3D Neural Network Models Generated from Stem Cells

By LabMedica International staff writers
Posted on 01 Nov 2018
A team of biomedical engineers worked with human induced pluripotent stem cells (iPSCs) to develop three-dimensional (3D) in vitro human neural network model systems.

Three-dimensional in vitro cell and tissue culture models allow for the exploration of mechanisms of organ development, cellular interactions, and disease progression within defined environments. More...
Investigators at Tufts University (Boston, MA, USA) used iPSCs from normal and diseased individuals to populate a three-dimensional matrix of silk protein and collagen to create such models, which would mimic structural and functional features of the brain and demonstrate neural activity.

The current work was based on previous studies where primary rodent neurons were successfully grown in a similar three-dimensional system. The model was adapted to human induced pluripotent stem cells, allowing for a more direct exploration of the human condition.

The investigators reported in the October 1, 2018, online edition of the journal ACS Biomaterials Science & Engineering that these tissue cultures comprised diverse cell populations, including neurons and astroglial cells, interacting in three-dimensions and exhibited spontaneous neural activity confirmed through electrophysiological recordings and calcium imaging over at least nine months. Compared to growing and culturing cells in two dimensions, the three-dimensional matrix produced a significantly more complete mix of cells found in neural tissue, with the appropriate morphology and expression of receptors and neurotransmitters.

This approach, which was tested with stem cells derived from healthy individuals as well as from Alzheimer’s and Parkinson’s disease patients, allowed for the direct integration of pluripotent stem cells into the three-dimensional construct, bypassing early neural differentiation steps. This streamlined process, in combination with the longevity of the cultures, provided a system that could be manipulated to support a variety of experimental applications such as investigating drug targets in neurodegenerative diseases.

"We found the right conditions to get the iPSCs to differentiate into a number of different neural subtypes, as well as astrocytes that support the growing neural networks," said senior author Dr. David L. Kaplan, professor of biomedical engineering at Tufts University. "The silk-collagen scaffolds provide the right environment to produce cells with the genetic signatures and electrical signaling found in native neuronal tissues."

Related Links:
Tufts University


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.